Senticell
Senticell is developing a liquid-biopsy diagnostic based on nucleic acids associated with red blood cells.
$7MSeed
ParticipantEC
Evoce Capital
Activity from announced rounds
Activity in this selectionquantumlight-f81f325b
- Rounds participated in
- 2
- Confirmed lead rounds
- 0 1 roles undisclosed
- New companies
- 2 First participation on record · 0 follow-on
- Funding in participating rounds
- $13M 2 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
2 in this selectionSurf Therapeutics
Develops non-invasive ultrasound neuromodulation therapies to treat immune-mediated diseases
$6MSeed
Role not disclosed